Literature DB >> 21793692

Changes in rigidity and symptoms among adolescents in psychodynamic psychotherapy.

Dana Atzil Slonim1, Gaby Shefler, Shira Dvir Gvirsman, Orya Tishby.   

Abstract

UNLABELLED: The present study examined changes in the rigidity of interpersonal patterns and symptoms in adolescents (ages 15-18) in a year-long psychodynamic psychotherapy. Seventy-two adolescents (30 in treatment and 42 in a non-treatment "community group") underwent Relationship Anecdote Paradigm (RAP) interviews according to the Core Conflictual Relationship Theme method (CCRT; Luborsky & Crits-Christoph, 1998), and completed outcome measures at two time points.
RESULTS: Adolescents in the treatment group became less rigid in their interpersonal patterns and improved significantly in their symptoms, whereas no such changes were observed in the community group. Levels of rigidity were not related to initial symptom distress; however, changes in rigidity were related to improvement in symptoms within the treatment group.

Entities:  

Mesh:

Year:  2011        PMID: 21793692     DOI: 10.1080/10503307.2011.602753

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  3 in total

1.  The Evidence-Base for Psychodynamic Psychotherapy With Children and Adolescents: A Narrative Synthesis.

Authors:  Nick Midgley; Rose Mortimer; Antonella Cirasola; Prisha Batra; Eilis Kennedy
Journal:  Front Psychol       Date:  2021-04-27

2.  Interactions between Obsessional Symptoms and Interpersonal Ambivalences in Psychodynamic Therapy: An Empirical Case Study.

Authors:  Shana Cornelis; Mattias Desmet; Kimberly L H D Van Nieuwenhove; Reitske Meganck; Jochem Willemsen; Ruth Inslegers; Jasper Feyaerts
Journal:  Front Psychol       Date:  2017-06-09

3.  Conflicted Anger as a Central Dynamic in Depression in Adolescents-A Double Case Study.

Authors:  Arne Kristian Henriksen; Randi Ulberg; Bjørn Peter Urban Tallberg; André Løvgren; Hanne-Sofie Johnsen Dahl
Journal:  Int J Environ Res Public Health       Date:  2021-06-15       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.